Authors

Lea Bucher
Recent : How a “Push and Pull” Approach Can Maximize Innovation Value through HTAs

Lea Bucher is Principal at

Cynthia Ingols, EdD
Recent : How GxP Leaders Can Assess and Approach a Company’s Quality Culture

Fellow, Institute for Inclusive Leadership, Professor of Practice (Retired), School of Business, Simmons University

Anita Moser
Recent : How AI Is Carving UCB’s Path to Better Patient Insights
Tiffany Mura
Recent : Using Service Design to Drive Value, Speed & Quality in the Regulatory Review Process

Tiffany Mura is VP Client Experience & Strategy, Health at Mad*Pow.

Spencer Morrison
Recent : Payers Believe Lowering Drug Prices While Improving Patient Access Is Possible—but There’s a Catch

Director, Leavitt Partners, an HMA Company

Scott Morano
Recent : The Truth About Telemedicine

Scott Morano is Vice President, Ipsos.

Robert LaCaze
Recent : When Innovation Outpaces HTA, Access Struggles to Keep Up

Member of the Executive Committee of Bayer AG’s Pharmaceuticals Division and Head of the Oncology Strategic Business Unit

Marco Quarta
Recent : The Rise of Longevity Therapeutics

Marco Quarta is CEO of Rubedo Life Sciences.

Rachel Seidman, Brand Insights Contributor, Vice President, Digital Innovation The Whyse
Recent : 5 Digital Trends You Need to Adopt This Year to Remain Top of Mind
Carolyn Zele
Recent : How Market Access Can Determine Commercial Success

Carolyn Zele is an advisor of solution consulting for MMIT (a Norstella company).